In yesterday’s pipeline update, Chris Peterson, PharmD, a director in the Emerging Therapeutics department at Express Scripts, reviewed the trend in FDA approvals and noted several of the key therapeutic areas with recent generics.
Ever since the Patient Protection and Affordable Care Act was signed into law, healthcare observers from all corners of the country have made predictions on everything from the ultimate cost of health reform to the percentage of the uninsured. There’s a mix of both optimism and pessimism. 2014 will provide us an opportunity to compare their predictions to the ultimate reality.Managed Healthcare Executive polled readers on their forecast for 2014 and beyond. Nearly 350 readers responded and their feedback is summarized here in our 2014 State of the Industry slideshow.